Page 2 - David Marek News Today

Funding to Accelerate Growth, Innovation, and Expansion into New Markets

BASEL, Switzerland, June 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, empowering medicines,

At a meeting on Wednesday, 18 May, Petr Fiala's government decided to reconvene the government's National Economic Council, approving new statutes and members for the body. The National Economic Council will have 19 members, all renowned economists, and its coordinator will be Jan Procházka, Chairma

Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe - read this article along with other careers information, tips and advice on BioSpace

Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer

ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in EuropeMyovant expects to secure European...

Tel Aviv, Israel (PRWEB) April 27, 2022 -- NetOp.Cloud, the cloud-based network operation management solution, today announced the company’s public launch,

COPENHAGEN, DK / ACCESSWIRE / April 22, 2022 / Linkfire (STO:LINKFI)(NASDAQ:LINKFI.ST) has signed a new marketing and affiliate agreement with Amazon Music, which is intended to support the growth of the

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

MYOV earnings call for the period ending December 31, 2021.